Abstract:To elucidate the molecular basis for the interaction of ligands with the human melanocortin-4, receptor (hMC4R), agonist structure-activity studies and receptor point mutagenesis were pet-formed. Structure-activity studies of [Nle(4),D-Phe(7)]-alpha -melanocyte stimulating hormone (NDP-MSH) identified D-Phe7-Arg8-Trp9 as the minimal NDP-MSH fragment that possesses full agonist efficacy at the hMC4R. In an effort to identify receptor residues that might interact with amino acids in this tripeptide sequence 24 hMC4R transmembrane (TM) residues were mutated (the rationale for choosing specific receptor residues for mutation is outlined in the Results section). Mutation of TM3 residues D122 and D126 and TM6 residues F261 and H264 decreased the binding affinity of NDP-MSH 5-fold or greater, thereby identifying these receptor residues as sites potentially involved in the sought after ligand-receptor interactions. By examination of the binding affinities and potencies of substituted NDP-MSH peptides at receptor mutants, evidence was found that core melanocortin peptide residue Arg8 interacts at a molecular level with hMC4R TM3 residue D122. TM3 mutations were also observed to decrease the binding of hMC4R antagonists. Notably, mutation of TM3 residue D126 to alanine decreased the binding affinity of AGRP (87-132), a C-terminal derivative of the endogenous melanocortin antagonist, 8-fold, and simultaneous mutations D122A/D126A completely abolished AGRP (87-132) binding. In addition, mutation of TM3 residue D122 or D126 decreased the binding affinity of hMC4R antagonist SHU 9119. These results provide further insight into the molecular determinants of hMC4R ligand binding.

Mechanisms of ligand recognition and activation of melanin-concentrating hormone receptors

Structural insights into physiological activation and antagonism of melanin-concentrating hormone receptor MCHR1

Structural mechanism of calcium-mediated hormone recognition and Gβ interaction by the human melanocortin-1 receptor

Structural insights into ligand recognition and subtype selectivity of the human melanocortin-3 and melanocortin-5 receptors

Identification and characterization of a melanin-concentrating hormone receptor

Structural insights into ligand recognition and activation of the melanocortin-4 receptor

Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR

Determination of the Interaction and Pharmacological Modulation of MCHR1 Signaling by the C-Terminus of MRAP2 Protein

Structural basis of signaling regulation of the human melanocortin-2 receptor by MRAP1

Molecular signatures of human melanocortin receptors for ligand binding and signaling

Molecular Determinants of Ligand Binding to the Human Melanocortin-4 Receptor

Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor

Molecular cloning and functional characterization of MCH2, a novel human MCH receptor

Arginine residue 155 in the second intracellular loop plays a critical role in rat melanin-concentrating hormone receptor 1 activation

Modeling and Docking of the Three-Dimensional Structure of the Human Melanocortin 4 Receptor

Ψ and χ Angle Constrains at the C-Terminus Trp Position of the Melanotropin Tetrapeptide Ac-His-d-Phe-Arg-Trp-NH2 Lead to Potent and Selective Agonists at hMC1R and hMC4R

Structures of active melanocortin-4 receptor-Gs-protein complexes with NDP-α-MSH and setmelanotide

Melanocortin-4 Receptor PLC Activation Is Modulated by an Interaction with the Monocarboxylate Transporter 8

Molecular Insights into Ligand Recognition and Activation of Chemokine Receptors CCR2 and CCR3

Characterization of Melanin-Concentrating Hormone (MCH) and Its Receptor in Chickens: Tissue Expression, Functional Analysis, and Fasting-Induced Up-Regulation of Hypothalamic MCH Expression.

Activation of the human chemokine receptor CX3CR1 regulated by cholesterol